Clinical effects of daily methamphetamine administration

Area of Science:

• Pharmacology
• Neuroscience
• Clinical Research

Background:

• Methamphetamine hydrochloride (HCl) is a stimulant with potential for tolerance development.
• Understanding the pharmacodynamics and disposition of methamphetamine HCl is crucial for assessing its clinical use and abuse potential.

Purpose of the Study:

• To investigate alterations in the disposition and pharmacodynamics of methamphetamine HCl following daily administration.
• To assess the development of tolerance to the physiological and subjective effects of methamphetamine HCl.

Main Methods:

• Six male volunteers received 10 mg of slow-release methamphetamine HCl daily for 13 days.
• Subjects were challenged with 10 mg of deuterated methamphetamine HCl on days 1 and 15 to differentiate drug concentrations.
• Heart rate, subjective "high" ratings, and plasma methamphetamine concentrations were measured on challenge days.

Main Results:

• A significant decrease in heart rate acceleration occurred on day 15 compared to day 1 [F(1,5) = 8.26, p <= 0.035].
• No significant changes were observed in subjective "high" ratings or plasma concentrations of deuterated methamphetamine.
• Tolerance developed specifically to the cardiovascular effects of methamphetamine HCl.

Conclusions:

• Daily administration of low-dose methamphetamine HCl did not alter its disposition or subjective effects.
• Tolerance to the heart rate-accelerating effects of methamphetamine HCl was observed, suggesting a selective physiological adaptation.
• These findings highlight the differential development of tolerance to various methamphetamine effects.